Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Parkinson's Disease

Free Subscription Articles published in Neurobiol Dis Retrieve available abstracts of 142 articles: HTML format

Single Articles

March 2026
1. CHEN K, Ji Y, Zhang R, Lu L, et al
   Linking subjective cognitive decline to glymphatic dysfunction in Parkinson's disease.
   Neurobiol Dis. 2026;221:107344.
   PubMed     Abstract available
   
   
   February 2026
2. CHENG B, Cheng S, Wei W, Pan C, et al
   Residential green space, natural environment, domestic garden, and the risk of Parkinson's disease: A prospective cohort study.
   Neurobiol Dis. 2026 Feb 25:107334. doi: 10.1016/j.nbd.2026.107334.
   PubMed     Abstract available
   
   
   
3. LIU J, Yu D, Liu Y, Yong Y, et al
   Cholinergic neurotransmission underlying visual hallucinations in Parkinson's disease: Integration of multimodal evidence and translational approaches.
   Neurobiol Dis. 2026;220:107316.
   PubMed     Abstract available
   
   
   
4. ZHENG Q, Lin X, Fei G, Xiao L, et al
   A neuropeptide receptor-enriched transcriptional state characterizes resilient dopaminergic neurons in Parkinson's disease.
   Neurobiol Dis. 2026;220:107303.
   PubMed     Abstract available
   
   
   
5. ATHIENITI E, Afxenti S, Minadakis G, Spyrou GM, et al
   Multi-omics dissection of Parkinson's patients in subgroups associated with motor and cognitive severity.
   Neurobiol Dis. 2026 Feb 2:107288. doi: 10.1016/j.nbd.2026.107288.
   PubMed     Abstract available
   
   
   
6. ROTH LM, Morozova O, Stohr J, Schapansky J, et al
   Astrocytic lysosome deficits reduce alpha-synuclein degradation and induce the spread of pathology.
   Neurobiol Dis. 2026;219:107277.
   PubMed     Abstract available
   
   
   January 2026
7. CUI J, Zhao D, Liu J, Qian J, et al
   Inhibition of the LHb glutamatergic pathway ameliorates depressive-like behaviors in a 6-hydroxydopamine-induced Parkinson's disease mouse model.
   Neurobiol Dis. 2026;220:107293.
   PubMed     Abstract available
   
   
   
8. FENG Y, Zhang W, Zhang D, Xu Y, et al
   Cerebellar contributions to cognitive deterioration in Parkinson's disease: Insights from multi-omics and longitudinal data.
   Neurobiol Dis. 2026 Jan 14:107275. doi: 10.1016/j.nbd.2026.107275.
   PubMed     Abstract available
   
   
   
9. MARANO M, Zizzo C, Cavallieri F, Avenali M, et al
   Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease.
   Neurobiol Dis. 2026 Jan 13:107271. doi: 10.1016/j.nbd.2026.107271.
   PubMed     Abstract available
   
   
   
10. BOONSTRA J, Michielse S, Temel Y, Jahanshahi A, et al
    Ultra-high-field (9.4 T) ex vivo diffusion MRI tractography reveals microstructural differences in Parkinson's disease motor subtypes.
    Neurobiol Dis. 2026;219:107266.
    PubMed     Abstract available
    
    
    December 2025
11. BALLOTTO L, Baratta T, Winterberg H, Dusanter C, et al
    Nuclear ASC speck formation in microglia is associated with inflammasome priming and is exacerbated in LRRK2-G2019S Parkinson's disease.
    Neurobiol Dis. 2025 Dec 25:107237. doi: 10.1016/j.nbd.2025.107237.
    PubMed     Abstract available
    
    
    
12. WANG M, Li Y, Yao J, Zhao W, et al
    Memory-guided saccade latency as a potential biomarker for axial symptoms and freezing of gait in Parkinson's disease.
    Neurobiol Dis. 2025 Dec 22:107238. doi: 10.1016/j.nbd.2025.107238.
    PubMed     Abstract available
    
    
    
13. REZA A, Yanagisawa T, Tani N, Fukuma R, et al
    Wirelessly transmitted subthalamic nucleus signals decode endogenous pain levels in Parkinson's disease patients.
    Neurobiol Dis. 2025 Dec 22:107235. doi: 10.1016/j.nbd.2025.107235.
    PubMed     Abstract available
    
    
    
14. RUAN X, Huang X, Wang M, Zhou Q, et al
    Network-wide morphometric organization deficits and transcriptomic correlates in Parkinson's disease with freezing of gait: A morphometric inverse divergence study.
    Neurobiol Dis. 2025 Dec 18:107230. doi: 10.1016/j.nbd.2025.107230.
    PubMed     Abstract available
    
    
    
15. BERNARD K, Corenblum MJ, Tonino P, Madhavan L, et al
    Bioenergetic and protein processing imbalances in iPSC-dopamine neurons from individuals with idiopathic Parkinson's disease.
    Neurobiol Dis. 2025 Dec 12:107222. doi: 10.1016/j.nbd.2025.107222.
    PubMed     Abstract available
    
    
    
16. HAWA Z, Mirpour K, Choi JW, Pouratian N, et al
    Beta burst characteristics predict instantaneous hand movements in Parkinson's disease.
    Neurobiol Dis. 2025;217:107157.
    PubMed     Abstract available
    
    
    November 2025
17. YIN P, Guan C, Niu X, Yang L, et al
    Corneal nerve loss measured by corneal confocal microscopy predicts pain severity in Parkinson's disease.
    Neurobiol Dis. 2025;217:107197.
    PubMed     Abstract available
    
    
    
18. DELIGANI RJ, Opri E, Risk BB, Goldstein F, et al
    Cortical beta power modulation is asymmetric and reduced during movement execution and inhibition in Parkinson's disease.
    Neurobiol Dis. 2025;217:107195.
    PubMed     Abstract available
    
    
    
19. AUNG KZ, Zin SS, Wu X, Myint ZW, et al
    Disentangling the inverse relationship between cancer and Alzheimer's or Parkinson's disease: A systematic review on Mendelian randomization studies.
    Neurobiol Dis. 2025;217:107190.
    PubMed     Abstract available
    
    
    
20. PARRELLA E, Gennari MM, Abate G, Pucci M, et al
    Early alpha-synuclein accumulation, oxidative stress and inflammation in the proximal colon of c-rel(-/-) mouse model of Parkinson's disease.
    Neurobiol Dis. 2025 Nov 7:107182. doi: 10.1016/j.nbd.2025.107182.
    PubMed     Abstract available
    
    
    
21. NACIRI LC, Melis M, Sollai G, Deligia S, et al
    A multi-dimensional study on taste deficits, alpha-synuclein genetic profiling, and supervised learning for diagnosis and disease severity stratification in Parkinson's disease (PD).
    Neurobiol Dis. 2025 Nov 3:107172. doi: 10.1016/j.nbd.2025.107172.
    PubMed     Abstract available
    
    
    October 2025
22. MIZUTANI Y, Nawashiro K, Ito S, Nakai T, et al
    Elevated TFEB expression with limited activation in peripheral blood mononuclear cells reflects altered lysosomal enzyme dynamics in Parkinson's disease.
    Neurobiol Dis. 2025;217:107151.
    PubMed     Abstract available
    
    
    
23. NUZZO T, Carrillo F, Serra M, Gentile C, et al
    Deep brain stimulation rescues the homeostasis disruption of circulating D- and L-amino acids level in men with Parkinson's disease.
    Neurobiol Dis. 2025 Oct 18:107150. doi: 10.1016/j.nbd.2025.107150.
    PubMed     Abstract available
    
    
    
24. YAN L, Ren J, Zhou H, Xing Y, et al
    Characterizing the distinct neuroanatomical phenotypes, cognitive profiles, and transcriptomic signatures of brain structural subtypes in Parkinson's disease with mild cognitive impairment.
    Neurobiol Dis. 2025 Oct 14:107141. doi: 10.1016/j.nbd.2025.107141.
    PubMed     Abstract available
    
    
    September 2025
25. RODICHKIN AN, Brown AM, Devabathini P, McGlothan JL, et al
    Cerebellar dysfunction in a mouse model of childhood-onset manganese-induced dystonia parkinsonism.
    Neurobiol Dis. 2025;216:107115.
    PubMed     Abstract available
    
    
    
26. LI P, Zhou X, Luo N, Zhou S, et al
    Dynamic cortical inhibition imbalance as a biomarker of clinical progression in early Parkinson's disease.
    Neurobiol Dis. 2025 Sep 3:107083. doi: 10.1016/j.nbd.2025.107083.
    PubMed     Abstract available
    
    
    
27. DUBACH L, Averna A, Alva L, Debove I, et al
    Unconsciousness reshapes the oscillatory topography of the subthalamic nucleus: A comparative study.
    Neurobiol Dis. 2025;213:107009.
    PubMed     Abstract available
    
    
    August 2025
28. BHARTI E, DeNicola AL, Yu Y, Verma AK, et al
    Alterations in beta oscillatory activity occur with the emergence of parkinsonian motor signs across the basal ganglia-thalamocortical network.
    Neurobiol Dis. 2025;215:107075.
    PubMed     Abstract available
    
    
    
29. CHEN T, Gong T, Chen Y, Yang A, et al
    Multimodal MRI biomarkers optimize differentiation between progressive supranuclear palsy and Parkinson's disease.
    Neurobiol Dis. 2025;215:107076.
    PubMed     Abstract available
    
    
    
30. GRILLO P, Di Martino D, Calculli A, De Icco R, et al
    Physical exercise modulates plasma irisin levels in endurance athletes: Implications for Parkinson's disease.
    Neurobiol Dis. 2025 Aug 23:107065. doi: 10.1016/j.nbd.2025.107065.
    PubMed     Abstract available
    
    
    
31. LUCAS-DEL-POZO S, Uras G, Fierli F, Lentini V, et al
    Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson's disease cell models.
    Neurobiol Dis. 2025 Aug 12:107053. doi: 10.1016/j.nbd.2025.107053.
    PubMed     Abstract available
    
    
    
32. BROWN HJ, Fan RZ, Bell R, Salehe SS, et al
    Imbalanced mitochondrial dynamics in human PD and alpha-synuclein mouse brains.
    Neurobiol Dis. 2025;212:106976.
    PubMed     Abstract available
    
    
    June 2025
33. ZHI Y, Chen K, You Y, Ji Y, et al
    Hypo-connected pattern in Parkinson's disease with pure apathy: A dynamic functional connectivity perspective.
    Neurobiol Dis. 2025;213:107008.
    PubMed     Abstract available
    
    
    
34. ZHU Z, Duanmu X, Zhou C, Wen J, et al
    Glymphatic dysfunction is related to motor disability fully mediated by gray matter degeneration in early-stage Parkinson's disease.
    Neurobiol Dis. 2025;213:107001.
    PubMed     Abstract available
    
    
    
35. CARRILLO F, Palomba NP, Pietracupa S, Ianiro L, et al
    ANKK1, ANKRD50, GRK5, PACSIN1 and VPS8 are novel candidate genes associated with late onset Parkinson's disease: Definition of a novel predictive protocol based on polygenic model of inheritance.
    Neurobiol Dis. 2025;213:106996.
    PubMed     Abstract available
    
    
    
36. SUN J, Chen L, Li L, Wu T, et al
    Less locus coeruleus degeneration and its enhanced influence on neural circuit in Parkinson's tremor.
    Neurobiol Dis. 2025 Jun 3:106960. doi: 10.1016/j.nbd.2025.106960.
    PubMed     Abstract available
    
    
    
37. YIN X, Wang M, Zhao F, Li F, et al
    Choroid plexus area and choroid plexus /lateral ventricle area index are potential imaging markers for freezing of gait in Parkinson's disease.
    Neurobiol Dis. 2025 Jun 2:106984. doi: 10.1016/j.nbd.2025.106984.
    PubMed     Abstract available
    
    
    May 2025
38. FALLETTI M, Asci F, Zampogna A, Patera M, et al
    Cogwheel rigidity in Parkinson's disease: Clinical, biomechanical and neurophysiological features.
    Neurobiol Dis. 2025;212:106980.
    PubMed     Abstract available
    
    
    
39. PARK G, Ha J, Lee JS, Ahn JH, et al
    Data-driven, cross-sectional image-based subtyping and staging of brain volumetric changes in Parkinson's disease.
    Neurobiol Dis. 2025;212:106970.
    PubMed     Abstract available
    
    
    
40. CVL D, Munro J, Berard M, Di Paolo T, et al
    Serotonin innervation of the subthalamic nucleus in parkinsonian monkeys.
    Neurobiol Dis. 2025 May 2:106938. doi: 10.1016/j.nbd.2025.106938.
    PubMed     Abstract available
    
    
    April 2025
41. MENG L, Wang D, Ma J, Shi Y, et al
    Unraveling Parkinson's disease motor subtypes: A deep learning approach based on spatiotemporal dynamics of EEG microstates.
    Neurobiol Dis. 2025 Apr 22:106915. doi: 10.1016/j.nbd.2025.106915.
    PubMed     Abstract available
    
    
    
42. XUE G, Wang G, Shi Q, Wang H, et al
    Exploring the dynamic pathogenesis of Parkinson's disease by case-control and longitudinal blood transcriptome analyses.
    Neurobiol Dis. 2025;209:106891.
    PubMed     Abstract available
    
    
    
43. WEN S, Li Y, Xiang W, Shen F, et al
    A novel mouse model of chronic neuronopathic Gaucher disease exhibits Parkinson's disease-like phenotypes.
    Neurobiol Dis. 2025;209:106899.
    PubMed     Abstract available
    
    
    March 2025
44. MINGO YB, Escobar Galvis ML, Henderson MX
    alpha-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease.
    Neurobiol Dis. 2025;209:106889.
    PubMed     Abstract available
    
    
    
45. YUAN YT, Hong WP, Tan CH, Yu RL, et al
    Influence of WWOX/MAF genes on cognitive performance in patients with Parkinson's disease.
    Neurobiol Dis. 2025;208:106887.
    PubMed     Abstract available
    
    
    
46. BUONOCORE A, Cafaro C, De Luca C, Vermiglio G, et al
    Lack of pre-movement facilitation as neurophysiological hallmark of fatigue in patients with Parkinson's disease: A single pulse TMS study.
    Neurobiol Dis. 2025;208:106878.
    PubMed     Abstract available
    
    
    
47. LINAN VS, Rioux V, Peralta M 3rd, Dupre N, et al
    Early detection of Parkinson's disease: Retinal functional impairments as potential biomarkers.
    Neurobiol Dis. 2025 Mar 14:106872. doi: 10.1016/j.nbd.2025.106872.
    PubMed     Abstract available
    
    
    
48. SUN H, Gan C, Cao X, Yuan Y, et al
    Microstructural and functional abnormalities of the locus coeruleus in freezing of gait in Parkinson's disease.
    Neurobiol Dis. 2025 Mar 9:106868. doi: 10.1016/j.nbd.2025.106868.
    PubMed     Abstract available
    
    
    
49. WANG B, Gannon M, Pattanayak R, Scholz K, et al
    14-3-3theta phosphorylation exacerbates alpha-synuclein aggregation and toxicity.
    Neurobiol Dis. 2025;206:106801.
    PubMed     Abstract available
    
    
    February 2025
50. WICHMANN T, Nelson A, Torres ERS, Svenningsson P, et al
    Leveraging animal models to understand non-motor symptoms of Parkinson's disease.
    Neurobiol Dis. 2025 Feb 27:106848. doi: 10.1016/j.nbd.2025.106848.
    PubMed     Abstract available
    
    
    
51. FREDLUND F, Fryklund C, Trujeque-Ramos O, Staley HA, et al
    Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-alpha-Syn?+?PFFs-induced rat model for Parkinson's disease.
    Neurobiol Dis. 2025 Feb 13:106841. doi: 10.1016/j.nbd.2025.106841.
    PubMed     Abstract available
    
    
    
52. DIAO Y, Yin Z, Zhao B, Xu Y, et al
    Abnormal neuronal activity in the subthalamic nucleus contributes to dysarthria in patients with Parkinson's disease.
    Neurobiol Dis. 2025 Feb 3:106830. doi: 10.1016/j.nbd.2025.106830.
    PubMed     Abstract available
    
    
    
53. HARTKE AS, Schreiber CS, Lau K, Wiesweg I, et al
    Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins.
    Neurobiol Dis. 2025;205:106773.
    PubMed     Abstract available
    
    
    January 2025
54. GUO T, Zhou C, Wen J, Wu J, et al
    Aberrant functional connectome gradient and its neurotransmitter basis in Parkinson's disease.
    Neurobiol Dis. 2025;206:106821.
    PubMed     Abstract available
    
    
    
55. DEL PERCIO C, Lizio R, Lopez S, Noce G, et al
    Resting-state electroencephalographic rhythms depend on sex in patients with dementia due to Parkinson's and Lewy Body diseases: An exploratory study.
    Neurobiol Dis. 2025;206:106807.
    PubMed     Abstract available
    
    
    
56. BOLEN ML, Gomes BN, Gill B, Menees KB, et al
    Peripheral blood immune cells from individuals with Parkinson's disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugs.
    Neurobiol Dis. 2025 Jan 11:106794. doi: 10.1016/j.nbd.2025.106794.
    PubMed     Abstract available
    
    
    December 2024
57. HUANG CW, Tsai HY, Lin YH, Lin WW, et al
    Striatal-cortical dysconnectivity underlies somatosensory deficits in Parkinson's disease: Insights from rhythmic auditory-motor training.
    Neurobiol Dis. 2024 Dec 22:106778. doi: 10.1016/j.nbd.2024.106778.
    PubMed     Abstract available
    
    
    October 2024
58. LAI MS, Sorensen MH, Lee K, Chu JM, et al
    3D mapping of direct VTA-CA2 circuit with potential involvement in Parkinson's disease degeneration.
    Neurobiol Dis. 2024;202:106723.
    PubMed     Abstract available
    
    
    
59. CARRILLO F, Palomba NP, Ghirimoldi M, Dido C, et al
    Multiomics approach discloses lipids and metabolites profiles associated to Parkinson's disease stages and applied therapies.
    Neurobiol Dis. 2024 Oct 18:106698. doi: 10.1016/j.nbd.2024.106698.
    PubMed     Abstract available
    
    
    
60. CAO C, Litvak V, Zhan S, Liu W, et al
    Low-beta versus high-beta band cortico-subcortical coherence in movement inhibition and expectation.
    Neurobiol Dis. 2024;201:106689.
    PubMed     Abstract available
    
    
    
61. MASSARI CM, Dues DJ, Bergsma A, Sipple K, et al
    Neuropathology in an alpha-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein.
    Neurobiol Dis. 2024;202:106701.
    PubMed     Abstract available
    
    
    
62. MENDONCA MD, Ferreira P, Barbosa R, da Silva JA, et al
    Brain-first forms of Parkinson's disease are over-represented in patients with non-responsive resting tremor.
    Neurobiol Dis. 2024;201:106691.
    PubMed     Abstract available
    
    
    
63. CHEN B, Zhou H, Liu X, Yang W, et al
    Correlations of gray matter volume with peripheral cytokines in Parkinson's disease.
    Neurobiol Dis. 2024 Oct 3:106693. doi: 10.1016/j.nbd.2024.106693.
    PubMed     Abstract available
    
    
    September 2024
64. LIU J, Ji Z, He Q, Chen H, et al
    Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment.
    Neurobiol Dis. 2024;201:106683.
    PubMed     Abstract available
    
    
    
65. SHEN B, Yao Q, Li W, Dong S, et al
    Dynamic cerebellar and sensorimotor network compensation in tremor-dominated Parkinson's disease.
    Neurobiol Dis. 2024;201:106659.
    PubMed     Abstract available
    
    
    
66. SERMON JJ, Wiest C, Tan H, Denison T, et al
    Evoked resonant neural activity long-term dynamics can be reproduced by a computational model with vesicle depletion.
    Neurobiol Dis. 2024;199:106565.
    PubMed     Abstract available
    
    
    August 2024
67. PARK DG, Kang W, Shin IJ, Chalita M, et al
    Difference in gut microbial dysbiotic patterns between body-first and brain-first Parkinson's disease.
    Neurobiol Dis. 2024;201:106655.
    PubMed     Abstract available
    
    
    
68. GRENNAN I, Mallet N, Magill PJ, Cagnan H, et al
    Beta bursts in the parkinsonian cortico-basal ganglia network form spatially discrete ensembles.
    Neurobiol Dis. 2024 Aug 27:106652. doi: 10.1016/j.nbd.2024.106652.
    PubMed     Abstract available
    
    
    
69. STETZIK L, Mercado G, Steiner JA, Lindquist A, et al
    Heterozygous loss of Engrailed-1 and alpha-synucleinopathy (En1/SYN): A dual-hit preclinical mouse model of Parkinson's disease, analyzed with artificial intelligence.
    Neurobiol Dis. 2024 Aug 24:106647. doi: 10.1016/j.nbd.2024.106647.
    PubMed     Abstract available
    
    
    
70. LI B, Dettmer U
    Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies.
    Neurobiol Dis. 2024 Aug 22:106646. doi: 10.1016/j.nbd.2024.106646.
    PubMed     Abstract available
    
    
    
71. MASSACCI G, Venafra V, Zwiebel M, Wahle M, et al
    Stage-dependent phosphoproteome remodeling of Parkinson's disease blood cells.
    Neurobiol Dis. 2024;200:106622.
    PubMed     Abstract available
    
    
    July 2024
72. CAMPAGNOLO M, Weis L, Sandre M, Tushevski A, et al
    Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort.
    Neurobiol Dis. 2024;200:106609.
    PubMed     Abstract available
    
    
    
73. ADOM MA, Hahn WN, McCaffery TD, Moors TE, et al
    Reducing the lipase LIPE in mutant alpha-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism.
    Neurobiol Dis. 2024;199:106593.
    PubMed     Abstract available
    
    
    
74. FASANO A, Mure H, Oyama G, Murase N, et al
    Subthalamic nucleus local field potential stability in patients with Parkinson's disease.
    Neurobiol Dis. 2024;199:106589.
    PubMed     Abstract available
    
    
    June 2024
75. MESAROSOVA L, Scheper M, Iyer A, Anink JJ, et al
    miR-193b-3p/ PGC-1alpha pathway regulates an insulin dependent anti-inflammatory response in Parkinson's disease.
    Neurobiol Dis. 2024 Jun 29:106587. doi: 10.1016/j.nbd.2024.106587.
    PubMed     Abstract available
    
    
    
76. LI X, Pang H, Bu S, Zhao M, et al
    Stage-dependent differential impact of network communication on cognitive function across the continuum of cognitive decline in Parkinson's disease.
    Neurobiol Dis. 2024 Jun 24:106578. doi: 10.1016/j.nbd.2024.106578.
    PubMed     Abstract available
    
    
    
77. TEZUKA T, Ishiguro M, Taniguchi D, Osogaguchi E, et al
    Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease.
    Neurobiol Dis. 2024 Jun 18:106571. doi: 10.1016/j.nbd.2024.106571.
    PubMed     Abstract available
    
    
    
78. MASATO A, Bubacco L
    The alphaSynuclein half-life conundrum.
    Neurobiol Dis. 2024;196:106524.
    PubMed     Abstract available
    
    
    
79. GAO AYL, Montagna DR, Hirst WD, Temkin PA, et al
    RIT2 regulates autophagy lysosomal pathway induction and protects against alpha-synuclein pathology in a cellular model of Parkinson's disease.
    Neurobiol Dis. 2024;199:106568.
    PubMed     Abstract available
    
    
    
80. BAARBE J, Brown MJN, Saha U, Tran S, et al
    Cortical modulations before lower limb motor blocks are associated with freezing of gait in Parkinson's disease: an EEG source localization study.
    Neurobiol Dis. 2024 Jun 7:106557. doi: 10.1016/j.nbd.2024.106557.
    PubMed     Abstract available
    
    
    
81. GAN C, Cao X, Sun H, Ye S, et al
    Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders.
    Neurobiol Dis. 2024;198:106560.
    PubMed     Abstract available
    
    
    
82. LEAVITT D, Alanazi FI, Al-Ozzi TM, Cohn M, et al
    Auditory oddball responses in the human subthalamic nucleus and substantia nigra pars reticulata.
    Neurobiol Dis. 2024;195:106490.
    PubMed     Abstract available
    
    
    
83. YAN S, Lu J, Duan B, Zhu H, et al
    Quantitative susceptibility mapping of multiple system atrophy and Parkinson's disease correlates with neurotransmitter reference maps.
    Neurobiol Dis. 2024;198:106549.
    PubMed     Abstract available
    
    
    May 2024
84. CASANOVA F, Tian Q, Williamson DS, Qian Y, et al
    MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort.
    Neurobiol Dis. 2024 May 22:106539. doi: 10.1016/j.nbd.2024.106539.
    PubMed     Abstract available
    
    
    
85. GULBERTI A, Schneider TR, Galindo-Leon EE, Heise M, et al
    Premotor cortical beta synchronization and the network neuromodulation of externally paced finger tapping in Parkinson's disease.
    Neurobiol Dis. 2024 May 11:106529. doi: 10.1016/j.nbd.2024.106529.
    PubMed     Abstract available
    
    
    
86. SHI D, Wu S, Zhuang C, Mao Y, et al
    Multimodal data fusion reveals functional and neurochemical correlates of Parkinson's disease.
    Neurobiol Dis. 2024 May 11:106527. doi: 10.1016/j.nbd.2024.106527.
    PubMed     Abstract available
    
    
    
87. ILIEVA NM, Hoffman EK, Ghalib MA, Greenamyre JT, et al
    LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.
    Neurobiol Dis. 2024 May 3:106522. doi: 10.1016/j.nbd.2024.106522.
    PubMed     Abstract available
    
    
    
88. HEMBACH S, Schmidt S, Orschmann T, Burtscher I, et al
    Engrailed 1 deficiency induces changes in ciliogenesis during human neuronal differentiation.
    Neurobiol Dis. 2024;194:106474.
    PubMed     Abstract available
    
    
    April 2024
89. GUO X, He S, Geng X, Yao P, et al
    Quantifying local field potential dynamics with amplitude and frequency stability between ON and OFF medication and stimulation in Parkinson's disease.
    Neurobiol Dis. 2024 Apr 27:106519. doi: 10.1016/j.nbd.2024.106519.
    PubMed     Abstract available
    
    
    
90. RURAK BK, Tan J, Rodrigues JP, Power BD, et al
    Cortico-cortical connectivity is influenced by levodopa in tremor-dominant Parkinson's disease.
    Neurobiol Dis. 2024;196:106518.
    PubMed     Abstract available
    
    
    
91. TREMBLAY C, Aslam S, Walker JE, Lorenzini I, et al
    RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction.
    Neurobiol Dis. 2024 Apr 23:106514. doi: 10.1016/j.nbd.2024.106514.
    PubMed     Abstract available
    
    
    
92. BUOSO C, Seifert M, Lang M, Griffith CM, et al
    Dopamine?iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease.
    Neurobiol Dis. 2024 Apr 20:106506. doi: 10.1016/j.nbd.2024.106506.
    PubMed     Abstract available
    
    
    
93. TONG B, Ba Y, Li Z, Yang C, et al
    Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
    Neurobiol Dis. 2024 Apr 18:106505. doi: 10.1016/j.nbd.2024.106505.
    PubMed     Abstract available
    
    
    
94. JIAO LL, Dong HL, Liu MM, Wu PL, et al
    The potential roles of salivary biomarkers in neurodegenerative diseases.
    Neurobiol Dis. 2024;193:106442.
    PubMed     Abstract available
    
    
    March 2024
95. IOVINO L, Vander Zwaag J, Kaur G, Khakpour M, et al
    Investigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease.
    Neurobiol Dis. 2024 Mar 23:106481. doi: 10.1016/j.nbd.2024.106481.
    PubMed     Abstract available
    
    
    
96. ZHOU C, You J, Guan X, Guo T, et al
    Microstructural alterations of the hypothalamus in Parkinson's disease and probable REM sleep behavior disorder.
    Neurobiol Dis. 2024 Mar 11:106472. doi: 10.1016/j.nbd.2024.106472.
    PubMed     Abstract available
    
    
    February 2024
97. HUANG YT, Chen YW, Lin TY, Chen JC, et al
    Suppression of presynaptic corticostriatal glutamate activity attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned Parkinson's disease mice.
    Neurobiol Dis. 2024;193:106452.
    PubMed     Abstract available
    
    
    
98. STOLL AC, Kemp CJ, Patterson JR, Howe JW, et al
    Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions.
    Neurobiol Dis. 2024;191:106411.
    PubMed     Abstract available
    
    
    January 2024
99. IMARISIO A, Yahyavi I, Avenali M, Di Maio A, et al
    Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease.
    Neurobiol Dis. 2024;192:106413.
    PubMed     Abstract available
    
    
    
100. WU C, Wu H, Zhou C, Guan X, et al
     Neurovascular coupling alteration in drug-naive Parkinson's disease: The underlying molecular mechanisms and levodopa's restoration effects.
     Neurobiol Dis. 2024 Jan 8:106406. doi: 10.1016/j.nbd.2024.106406.
     PubMed     Abstract available
     
     
     
101. SALIN P, Melon C, Chassain C, Gubellini P, et al
     Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism.
     Neurobiol Dis. 2024;191:106398.
     PubMed     Abstract available
     
     
     December 2023
102. TRAN S, Heida TC, Heijs JJA, Al-Ozzi T, et al
     Subthalamic and pallidal neurons are modulated during externally cued movements in Parkinson's disease.
     Neurobiol Dis. 2023 Dec 20:106384. doi: 10.1016/j.nbd.2023.106384.
     PubMed     Abstract available
     
     
     
103. LIANG K, Li X, Guo Q, Ma J, et al
     Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
     Neurobiol Dis. 2023;190:106379.
     PubMed     Abstract available
     
     
     
104. DI LAZZARO G, Picca A, Boldrini S, Bove F, et al
     Differential profiles of serum cytokines in Parkinson's disease according to disease duration.
     Neurobiol Dis. 2023 Dec 5:106371. doi: 10.1016/j.nbd.2023.106371.
     PubMed     Abstract available
     
     
     November 2023
105. TSHILENGE KT, Bons J, Aguirre CG, Geronimo-Olvera C, et al
     Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
     Neurobiol Dis. 2023 Nov 30:106367. doi: 10.1016/j.nbd.2023.106367.
     PubMed     Abstract available
     
     
     
106. TOFFOLI M, Chohan H, Mullin S, Jesuthasan A, et al
     Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study.
     Neurobiol Dis. 2023 Nov 3:106343. doi: 10.1016/j.nbd.2023.106343.
     PubMed     Abstract available
     
     
     
107. HARVEY J, Pishva E, Chouliaras L, Lunnon K, et al
     Elucidating distinct molecular signatures of Lewy body dementias.
     Neurobiol Dis. 2023;188:106337.
     PubMed     Abstract available
     
     
     
108. TUBERT C, Zampese E, Pancani T, Tkatch T, et al
     Feed-forward metabotropic signaling by Cav1 Ca(2+) channels supports pacemaking in pedunculopontine cholinergic neurons.
     Neurobiol Dis. 2023;188:106328.
     PubMed     Abstract available
     
     
     
109. DUES DJ, Ma Y, Nguyen APT, Offerman AV, et al
     Formation of templated inclusions in a forebrain alpha-synuclein mouse model is independent of LRRK2.
     Neurobiol Dis. 2023;188:106338.
     PubMed     Abstract available
     
     
     October 2023
110. RIVAS-SANTISTEBAN R, Rico A, Munoz A, Rodriguez AI, et al
     Boolean analysis shows a high proportion of dopamine D(2) receptors interacting with adenosine A(2A) receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease.
     Neurobiol Dis. 2023 Oct 31:106341. doi: 10.1016/j.nbd.2023.106341.
     PubMed     Abstract available
     
     
     
111. CHEN L, Sun J, Gao L, Wang J, et al
     Dysconnectivity of the parafascicular nucleus in Parkinson's disease: A dynamic causal modeling analysis.
     Neurobiol Dis. 2023;188:106335.
     PubMed     Abstract available
     
     
     
112. LAU K, Porschen LT, Richter F, Gericke B, et al
     Microvascular blood-brain barrier alterations in isolated brain capillaries of mice over-expressing alpha-synuclein (Thy1-aSyn line 61).
     Neurobiol Dis. 2023;187:106298.
     PubMed     Abstract available
     
     
     
113. LI T, Liu T, Zhang J, Ma Y, et al
     Neurovascular coupling dysfunction of visual network organization in Parkinson's disease.
     Neurobiol Dis. 2023;188:106323.
     PubMed     Abstract available
     
     
     
114. MAPLE-GRODEM J, Ushakova A, Pedersen KF, Tysnes OB, et al
     Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach.
     Neurobiol Dis. 2023;186:106281.
     PubMed     Abstract available
     
     
     
115. SCHAFFNER SL, Wassouf Z, Hentrich T, Nuesch-Germano M, et al
     Distinct impacts of alpha-synuclein overexpression on the hippocampal epigenome of mice in standard and enriched environments.
     Neurobiol Dis. 2023;186:106274.
     PubMed     Abstract available
     
     
     September 2023
116. DE FABREGUES O, Selles M, Ramos-Vicente D, Roch G, et al
     Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson's disease and examination of its possible etiologies: infectious or autoimmune?
     Neurobiol Dis. 2023 Sep 21:106308. doi: 10.1016/j.nbd.2023.106308.
     PubMed     Abstract available
     
     
     
117. TRINH D, Israwi AR, Brar H, Villafuerte JEA, et al
     Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy.
     Neurobiol Dis. 2023 Sep 11:106287. doi: 10.1016/j.nbd.2023.106287.
     PubMed     Abstract available
     
     
     August 2023
118. GRONLIER E, Volle J, Coizet V, Paccard A, et al
     Evoked responses to single pulse electrical stimulation reveal impaired striatal excitability in a rat model of Parkinson's disease.
     Neurobiol Dis. 2023 Aug 19:106266. doi: 10.1016/j.nbd.2023.106266.
     PubMed     Abstract available
     
     
     
119. GAN C, Ji M, Sun H, Cao X, et al
     Dynamic functional connectivity reveals hyper-connected pattern and abnormal variability in freezing of gait of Parkinson's disease.
     Neurobiol Dis. 2023;185:106265.
     PubMed     Abstract available
     
     
     
120. REN J, Yan L, Zhou H, Pan C, et al
     Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease.
     Neurobiol Dis. 2023 Aug 7:106254. doi: 10.1016/j.nbd.2023.106254.
     PubMed     Abstract available
     
     
     
121. DUMONT M, Agostinis A, Singh K, Swan E, et al
     Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies.
     Neurobiol Dis. 2023;184:106214.
     PubMed     Abstract available
     
     
     
122. BHATIA TN, Jamenis AS, Abbas M, Clark RN, et al
     A 14-day pulse of PLX5622 modifies alpha-synucleinopathy in preformed fibril-infused aged mice of both sexes.
     Neurobiol Dis. 2023;184:106196.
     PubMed     Abstract available
     
     
     July 2023
123. CROCKETT RA, Wilkins KB, Aditham S, Bronte-Stewart HM, et al
     No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment.
     Neurobiol Dis. 2023 Jul 29:106243. doi: 10.1016/j.nbd.2023.106243.
     PubMed     Abstract available
     
     
     
124. URSO D, Batzu L, Logroscino G, Chaudhuri KR, et al
     Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease.
     Neurobiol Dis. 2023 Jul 25:106237. doi: 10.1016/j.nbd.2023.106237.
     PubMed     Abstract available
     
     
     
125. AVANTAGGIATO F, Farokhniaee A, Bandini A, Palmisano C, et al
     Intelligibility of speech in Parkinson's disease relies on anatomically segregated subthalamic beta oscillations.
     Neurobiol Dis. 2023 Jul 25:106239. doi: 10.1016/j.nbd.2023.106239.
     PubMed     Abstract available
     
     
     
126. WANG Y, Xia Y, Kou L, Yin S, et al
     Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease.
     Neurobiol Dis. 2023 Jul 9:106224. doi: 10.1016/j.nbd.2023.106224.
     PubMed     Abstract available
     
     
     
127. LEGAZ A, Prado P, Moguilner S, Baez S, et al
     Social and non-social working memory in neurodegeneration.
     Neurobiol Dis. 2023;183:106171.
     PubMed     Abstract available
     
     
     June 2023
128. WU H, Wu C, Qin J, Zhou C, et al
     Functional connectome predicting individual gait function and its relationship with molecular architecture in Parkinson's disease.
     Neurobiol Dis. 2023;184:106216.
     PubMed     Abstract available
     
     
     
129. DI MAIO A, Nuzzo T, Gilio L, Serra M, et al
     Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
     Neurobiol Dis. 2023 Jun 17:106203. doi: 10.1016/j.nbd.2023.106203.
     PubMed     Abstract available
     
     
     
130. BATZU L, Urso D, Grothe MJ, Vereb D, et al
     Increased basal forebrain volumes could prevent cognitive decline in LRRK2 Parkinson's disease.
     Neurobiol Dis. 2023 Jun 5:106182. doi: 10.1016/j.nbd.2023.106182.
     PubMed     Abstract available
     
     
     
131. ZHONG M, Wang Y, Lin G, Liao FF, et al
     Dopamine-independent development and maintenance of mouse striatal medium spiny neuron dendritic spines.
     Neurobiol Dis. 2023;181:106096.
     PubMed     Abstract available
     
     
     May 2023
132. LUCHETTI S, Liere P, Pianos A, Verwer RWH, et al
     Disease stage-dependent changes in brain levels and neuroprotective effects of neuroactive steroids in Parkinson's disease.
     Neurobiol Dis. 2023 May 29:106169. doi: 10.1016/j.nbd.2023.106169.
     PubMed     Abstract available
     
     
     
133. YIN Z, Jiang Y, Merk T, Neumann WJ, et al
     Pallidal activities during sleep and sleep decoding in dystonia, Huntington's, and Parkinson's disease.
     Neurobiol Dis. 2023 May 3:106143. doi: 10.1016/j.nbd.2023.106143.
     PubMed     Abstract available
     
     
     
134. FAYARD A, Fenyi A, Lavisse S, Dovero S, et al
     Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: A pilot study in non-human primates.
     Neurobiol Dis. 2023;180:106086.
     PubMed     Abstract available
     
     
     
135. CHEN Z, Reynolds RH, Pardinas AF, Gagliano Taliun SA, et al
     The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases.
     Neurobiol Dis. 2023;180:106082.
     PubMed     Abstract available
     
     
     April 2023
136. GUERRA A, Colella D, Cannavacciuolo A, Giangrosso M, et al
     Short-term plasticity of the motor cortex compensates for bradykinesia in Parkinson's disease.
     Neurobiol Dis. 2023;182:106137.
     PubMed     Abstract available
     
     
     
137. HAYLEY S, Vahid-Ansari F, Sun H, Albert PR, et al
     Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models.
     Neurobiol Dis. 2023 Apr 8:106115. doi: 10.1016/j.nbd.2023.106115.
     PubMed     Abstract available
     
     
     
138. SASIKUMAR S, Sorrento G, Lang AE, Strafella AP, et al
     Cognition affects gait adaptation after split-belt treadmill training in Parkinson's disease.
     Neurobiol Dis. 2023 Apr 3:106109. doi: 10.1016/j.nbd.2023.106109.
     PubMed     Abstract available
     
     
     March 2023
139. CAULFIELD ME, Vander Werp MJ, Stancati JA, Collier TJ, et al
     Downregulation of striatal Ca(V)1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age.
     Neurobiol Dis. 2023 Mar 29:106111. doi: 10.1016/j.nbd.2023.106111.
     PubMed     Abstract available
     
     
     
140. HUANG Q, Chen C, Chen W, Cai C, et al
     Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease.
     Neurobiol Dis. 2023;180:106105.
     PubMed     Abstract available
     
     
     
141. TAN S, Zhou C, Wen J, Duanmu X, et al
     Presence but not the timing of onset of REM sleep behavior disorder distinguishes evolution patterns in Parkinson's disease.
     Neurobiol Dis. 2023;180:106084.
     PubMed     Abstract available
     
     
     
142. PORRINI V, Pilotto A, Vezzoli M, Lanzillotta A, et al
     NF-kappaB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients.
     Neurobiol Dis. 2023 Mar 7:106067. doi: 10.1016/j.nbd.2023.106067.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum